North America Multiple Sclerosis Therapeutics Market was valued at US$ 9,144.98 million in 2019 and is projected to reach US$ 15,269.74 million by 2027 with a CAGR of 6.8% during the forecast period 2020 to 2027 segmented into Drug Class, Route of Administration and Distribution Channel.
read more..